Malignant tumor of prostate (disorder)
ProCAID
Year Started: 2014
Serum, plasma and buffy coat isolated from whole blood at each treatment cycle. FFPE blocks also collected.
- Access:
- Access restricted at present
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Freezer temperature logs | 0 - 3 months |
| Quality indicators | 0 - 3 months |
Male
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Plasma | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Serum | -60°C to -85°C | N/A | Not applicable | 26 - 50% | |
| Tissue specimen | Surgical procedure (procedure) | RT | Paraffin | Not applicable | 0 - 10% |